Sort by
Refine Your Search
-
University of California, San Francisco | San Francisco, California | United States | about 2 months ago
is $28.04 - $45.09 (Hourly Rate). To learn more about the benefits of working at UCSF, including total compensation, please visit: https://ucnet.universityofcalifornia.edu/compensation-and-benefits
-
errors. Process bacterial and fungal cultures for all specimen types. Prepare and stain direct smears, including but not limited to, Gram stains, KOH preps, Trichromes, malaria preps. Answer phone calls
-
health, malaria, sexually transmitted infections, reproductive health, and immunology. The School’s and Department’s NIH rankings have steadily improved over the last five years with over 100% increase in
-
the Lifecourse; Global Viral and Bacterial Infections; Malaria and Neglected Parasitic Diseases and Maternal Child and Reproductive Health. ISGlobal is accredited with the Severo Ochoa distinction, a seal of
-
separation. Lab Chip 20: 614-625. Hosseini SM & Feng JJ (2012). How malaria parasites reduce the deformability of infected red blood cells. Biophys J 103: 1–10. https://doi.org/10.1016/j.bpj.2012.05.026 Mott A
-
Health over the Lifecourse; Global Viral and Bacterial Infections; Malaria and Neglected Parasitic Diseases and Maternal Child and Reproductive Health. ISGlobal is accredited with the Severo Ochoa
-
“Ultrastructural basis of the development and transmission of malaria parasites”. The position is full-time and for two years in the first instance, starting June 1, 2026, or upon agreement. The host laboratory is
-
, Nature and Urban Health; Environment and Health over the Lifecourse; Global Viral and Bacterial Infections; Malaria and Neglected Parasitic Diseases and Maternal Child and Reproductive Health. ISGlobal is
-
; Environment and Health over the Lifecourse; Global Viral and Bacterial Infections; Malaria and Neglected Parasitic Diseases and Maternal Child and Reproductive Health. ISGlobal is accredited with the Severo
-
responses to vaccination and/or infection for diseases of global importance, including assessment of clinical trials for candidate malaria, tuberculosis, monkey Pox, and HIV-1 vaccines. The study results